Advertisement
Every year about 23

About 23,000 ER Visits/Year for Supplement-Linked Side Effects

0
Visits often involve adults aged 20 to 34 years and unsupervised children

Doxycycline May Cut Bleeding With Ventricular Assist Device

0
ADAMTS-13 is clinical target to cut pathologic vWF degradation with LVAD support
For men who have sex with men

HAART Tied to Lower HBV Rate in Men Who Have Sex With Men

0
Risk factors for incident HBV include younger age, more than one sexual partner, HIV infection
Lithium safely and effectively reduces manic symptoms in pediatric patients treated for bipolar I disorder

Lithium Safe, Effective for Bipolar I Disorder in Children

0
The drug is well-tolerated in pediatric patients, reduces manic symptoms
Trends in opioid use and treatment of opioid use disorder are described in two studies published online Oct. 13 in the Journal of the American Medical Association.

Prescription Opioid Use Disorders Up From 2003 to 2013

0
Second study shows no increase in treatment for individuals with opioid use disorders
Primary care providers are the sole physician managers for more than one-third of children receiving mental health care

One-Third of Children See PCPs for Mental Health Conditions

0
More than 40 percent of children with ADHD see primary care provider only
When compared to 12 other industrialized nations

Americans Spend More on Health Care, but Fare Worse

0
Comparison with 12 industrialized nations shows more money spent, but life expectancy is lowest
Older kidney cancer patients treated with sorafenib or sunitinib may face an increased risk of cardiovascular adverse events

Sorafenib, Sunitinib May Pose Cardiovascular Risk

0
Higher stroke risk found in older kidney cancer patients taking the drugs

Infectious Diseases Society of America, Oct. 7-11

0
The Infectious Diseases Society of America annual meeting (IDWeek 2015) The annual meeting of the Infectious Diseases Society of America was...
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced non-small-cell lung cancer whose disease progressed despite platinum-based chemotherapy.

FDA Approves Expanded Use of Opdivo in Advanced Lung Cancer

0
Demonstrates survival benefit in both squamous and non-squamous non-small-cell lung cancer